NAOV

NanoVibronix, Inc. [NAOV] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

NAOV Stock Summary

Top 10 Correlated ETFs

NAOV


Top 10 Correlated Stocks

NAOV


In the News

10:32 26 Mar 2023 NAOV

What Is Going on With NanoVibronix (NAOV) Stock Today?

NanoVibronix (NASDAQ: NAOV ) stock is falling on Tuesday following news of a registered direct offering from the therapeutic ultrasound technology company. This direct offering has NanoVirbronix agreeing to sell 4.8 million shares of NAOV stock to several institutional investors.

11:31 26 Mar 2023 NAOV

Long Term Penny Stocks Investing Strategy (Complete Guide)

Use this guide for investing in penny stocks in the long term The post Long Term Penny Stocks Investing Strategy (Complete Guide) appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

04:05 26 Mar 2023 NAOV

NanoVibronix Sets Date for Annual Shareholder Meeting

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), announced today that its annual meeting of shareholders (the “Annual Meeting”) will take place at 10 a.m. Eastern time on December 15, 2022. The Company will hold the Annual Meeting virtually via the internet. The record date for determination of shareholders entitled to vote at the Annual Meeting is October 17, 2022. The Company anticipates sending proxy materials for the Annual Meeting to stockholders in Nove

03:30 26 Mar 2023 NAOV

Best Penny Stocks to Buy Now? Here's 3 to Watch in April 2022

Can these penny stocks continue to make moves next month? The post Best Penny Stocks to Buy Now?

01:41 26 Mar 2023 NAOV

Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?

Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday and we know why! The post Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?

11:27 26 Mar 2023 NAOV

Health Canada Approves NanoVibronix's PainGuard, UroGuard As Licensed Devices

NanoVibronix Inc's (NASDAQ: NAOV) PainGuard and UroGuard have been approved by Health Canada / Santé Canada as licensed medical devices. The products are offered as private label products through Ideal Medical International Limited.

03:15 26 Mar 2023 NAOV

NanoVibronix, Medina Ink Distribution Pact For Ultrasound Devices In Europe

NanoVibronix Inc (NASDAQ: NAOV) has commenced sales in Europe by signing a distribution agreement with Medina Healthcare Ltd for UroShield and PainShield devices. UroShield is an ultrasound-based product designed to prevent bacterial colonization and biofilm on indwelling urinary catheters and increase antibiotic efficacy, ultimately reducing the incidence of catheter-associated urinary tract infections (CAUTI).

09:06 26 Mar 2023 NAOV

Top Penny Stocks to Know in Mid-October 2021? 3 to Watch

Are these penny stocks on your October watchlist? The post Top Penny Stocks to Know in Mid-October 2021?

10:40 26 Mar 2023 NAOV

NanoVibronix Shares Gain As PainShield Shows Effectiveness In Treating Soft Tissue Pain

NanoVibronix Inc (NASDAQ:NAOV) has announced results from a randomized, double-blind study to evaluate the safety and effectiveness of the NanoVibronix PainShield. Related:   NanoVibronix Launches CBD-Based Product For Pain Management.

09:50 26 Mar 2023 NAOV

NAOV Stock: Why It Substantially Increased Today

The stock price of NanoVibronix, Inc., (NASDAQ: NAOV) increased by over 25% during intraday today. This is why it happened.

NAOV Financial details

Company Rating
Neutral
Market Cap
6M
Income
-5.86M
Revenue
1.63M
Book val./share
2.25
Cash/share
1.41
Dividend
-
Dividend %
-
Employees
12
Optionable
No
Shortable
Yes
Earnings
14 Nov 2022
P/E
-0.87
Forward P/E
-
PEG
0.18
P/S
3.14
P/B
1.62
P/C
2.59
P/FCF
-0.91
Quick Ratio
2
Current Ratio
2.91
Debt / Equity
0.65
LT Debt / Equity
-
-
-
EPS (TTM)
-4.32
EPS next Y
-
EPS next Q
-
EPS this Y
35.15%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-10.71%
Revenue last 5Y
47.96%
Revenue Q/Q
-80%
EPS Q/Q
-26.65%
-
-
-
-
SMA20
-18.33%
SMA50
-39.21%
SMA100
-57.89%
Inst Own
9.4%
Inst Trans
3.54%
ROA
-113%
ROE
-124%
ROC
-1.66%
Gross Margin
44%
Oper. Margin
-357%
Profit Margin
-360%
Payout
-
Shs Outstand
1.64M
Shs Float
1.39M
-
-
-
-
Target Price
-
52W Range
2.94-27.2
52W High
-86.48%
52W Low
+82.5%
RSI
43.25
Rel Volume
0.49
Avg Volume
84.72K
Volume
41.7K
Perf Week
7.04%
Perf Month
-16.67%
Perf Quarter
-60.33%
Perf Half Y
-60.02%
-
-
-
-
Beta
0.928796
-
-
Volatility
0.14%, 0.6%
Prev Close
3.11%
Price
3.65
Change
-3.82%

NAOV Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
0.960.991.531.211.35
Net income per share
-20-12.88-16.7-8.4-11.35
Operating cash flow per share
-8.79-11.01-11.17-6.59-3.47
Free cash flow per share
-8.79-11.04-11.17-6.59-3.47
Cash per share
17.572.783.8613.876.15
Book value per share
14.641.443.894.655.02
Tangible book value per share
14.641.443.894.655.02
Share holders equity per share
14.641.443.894.655.02
Interest debt per share
4.970.070.180.350
Market cap
23.23M23.35M19.78M7.87M26.17M
Enterprise value
18.87M22.45M18.44M757.79K18.48M
P/E ratio
-4.68-5.62-3.41-1.82-1.83
Price to sales ratio
97.273.4337.3212.6315.44
POCF ratio
-10.65-6.58-5.11-2.32-5.99
PFCF ratio
-10.65-6.56-5.11-2.32-5.99
P/B Ratio
6.3950.4314.673.294.15
PTB ratio
6.3950.4314.673.294.15
EV to sales
78.9670.6134.791.2210.9
Enterprise value over EBITDA
-5.12-5.28-3.21-0.18-1.29
EV to operating cash flow
-8.65-6.33-4.76-0.22-4.23
EV to free cash flow
-8.65-6.31-4.76-0.22-4.23
Earnings yield
-0.21-0.18-0.29-0.55-0.55
Free cash flow yield
-0.09-0.15-0.2-0.43-0.17
Debt to equity
0.342.410.512.440.37
Debt to assets
0.250.710.340.710.27
Net debt to EBITDA
1.180.210.231.710.54
Current ratio
5.671.924.492.754.38
Interest coverage
-2.5-195.59-83.08-32.1118.4
Income quality
0.440.850.670.780.31
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
8.728.297.216.052.98
Research and developement to revenue
2.91.930.970.270.17
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
0-0.03000
Capex to depreciation
0-1.330-1-1.5
Stock based compensation to revenue
3.352.83.310.60.23
Graham number
81.1820.438.2129.6435.8
ROIC
0.7710.316.680.760.82
Return on tangible assets
-1.02-2.63-2.85-0.53-1.66
Graham Net
12.87-0.132.332.814.54
Working capital
3.72M586K1.43M5.07M6.44M
Tangible asset value
3.63M463K1.35M2.39M6.31M
Net current asset value
3.29M109K1.15M2.14M6.03M
Invested capital
0000.010.01
Average receivables
24.5K89.5K137K111.5K178.5K
Average payables
125K180.5K161K136.5K115.5K
Average inventory
71.5K110K132.5K133K160K
Days sales outstanding
53.45165.2889.5354.4956.85
Days payables outstanding
696.82445.85189.1128.5134.33
Days of inventory on hand
315.23332.66177.37129.469.05
Receivables turnover
6.832.214.086.76.42
Payables turnover
0.520.821.932.8410.63
Inventory turnover
1.161.12.062.825.29
ROE
-1.37-8.97-4.3-1.81-2.26
Capex per share
0-0.02000

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
0.380.590.190.350.07
Net income per share
-5.12-1.9-0.81-0.93-0.68
Operating cash flow per share
-0.49-0.66-1.24-1.43-1.4
Free cash flow per share
-0.49-0.66-1.24-1.43-1.4
Cash per share
6.595.934.282.821.41
Book value per share
6.684.843.762.952.25
Tangible book value per share
6.684.843.762.952.25
Share holders equity per share
6.684.843.762.952.25
Interest debt per share
00.020.020.020.03
Market cap
53.76M27.14M32.48M17.64M12.88M
Enterprise value
45.18M19.45M26.53M13.73M10.93M
P/E ratio
-2.01-2.74-7.17-3.39-3.37
Price to sales ratio
107.7335.02119.436.37132.77
POCF ratio
-84.79-31.45-18.65-8.82-6.56
PFCF ratio
-84.66-31.45-18.65-8.81-6.55
P/B Ratio
6.174.36.174.274.08
PTB ratio
6.174.36.174.274.08
EV to sales
90.5425.197.5428.3112.73
Enterprise value over EBITDA
-6.82-7.64-23.31-10.67-11.85
EV to operating cash flow
-71.26-22.54-15.24-6.87-5.57
EV to free cash flow
-71.15-22.54-15.24-6.86-5.56
Earnings yield
-0.12-0.09-0.03-0.07-0.07
Free cash flow yield
-0.01-0.03-0.05-0.11-0.15
Debt to equity
0.110.370.460.580.65
Debt to assets
0.10.270.310.370.39
Net debt to EBITDA
1.293.025.223.042.11
Current ratio
35.434.383.683.072.91
Interest coverage
37.74132.1185.540-57.75
Income quality
0.090.351.541.542.06
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.613.13.462.387.61
Research and developement to revenue
0.10.150.240.130.51
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
0000-0.02
Capex to depreciation
0000-2
Stock based compensation to revenue
-0.190.350.320.45-0.2
Graham number
27.7214.378.277.865.88
ROIC
0.120.350.250.85-0.77
Return on tangible assets
-0.69-0.29-0.15-0.2-0.18
Graham Net
6.294.383.252.21.28
Working capital
9.16M6.44M5.38M4.26M3.27M
Tangible asset value
8.71M6.31M5.26M4.13M3.15M
Net current asset value
8.47M6.03M4.99M3.9M2.93M
Invested capital
00.010.010.010.01
Average receivables
666K444.5K654.5K1.24M1.45M
Average payables
121.5K74.5K129.5K172.5K107K
Average inventory
203K188K265K641.5K1.24M
Days sales outstanding
112.7330.66345.77266.661.36K
Days payables outstanding
20.5915.1293.2576.32217.06
Days of inventory on hand
66.7530.41192.47409.418.22K
Receivables turnover
0.82.940.260.340.07
Payables turnover
4.375.950.971.180.41
Inventory turnover
1.352.960.470.220.01
ROE
-0.77-0.39-0.22-0.31-0.3
Capex per share
00000

NAOV Frequently Asked Questions

What is NanoVibronix, Inc. stock symbol ?

NanoVibronix, Inc. is a US stock , located in Elmsford of Ny and trading under the symbol NAOV

What is NanoVibronix, Inc. stock quote today ?

NanoVibronix, Inc. stock price is $3.65 today.

Is NanoVibronix, Inc. stock public?

Yes, NanoVibronix, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap